SlideShare a Scribd company logo
1 of 2
Download to read offline
As of 2/3/2015: Schedule subject to change. Waldorf Astoria Hotel www.bio.org/bioceo
- 1 - New York, NY biopartnering@bio.org
Monday
Feb 9, 2015
Conrad Duke of Windsor Park South Park North Louis XVI Jade/Astor
1x1
Timeslots
4
th
Floor 3
rd
Floor 8
th
Floor
6:30 – 8:00am Networking Breakfast: Grand Ballroom
8:00 – 8:25am Admedus Ltd.
CASI
Pharmaceuticals
TBA
Innovus Pharma Genocea BioSciences Therapeutic Workshop:
Personalizing Oncology
Treatments (Jade)
1x1 (1)Highland Therapeutics
8:30 – 8:55am StemCells Inc.
Cellectar
Biosciences
Global Blood Therapeutics
Cara Therapeutics Dipexium Pharmaceuticals 1x1 (2)Michael J. Fox Foundation
9:00 – 9:25am RXi Pharmaceuticals Novogen
MaxCyte Aquinox
Pharmaceuticals
ContraFect Corporation 1x1 (3)
KineMed, Inc.
9:30 – 9:55am Ocata Therapeutics OncoSec Medical
EnGeneIc
Biotron Inovio Pharmaceuticals Business Roundtable:
Emerging Trends in
Deal Structures (Jade)
1x1 (4)
G1 Therapeutics
10:00 – 10:25am
Navidea
Biopharmaceuticals
NeoStem
Syndax Pharmaceuticals
Pfenex Immunovaccine Inc. 1x1 (5)
Mirna Therapeutics
10:30 – 10:55am Can-Fite Biopharma Resverlogix
Isarna Therapeutics Marinus
Pharmaceuticals
EnteroMedics 1x1 (6)
Anergis SA
11:00 – 11:25am Opexa Therapeutics
SciClone
Pharmaceuticals
Juventas Therapeutics
Recro Pharma Ligand Pharmaceuticals
Therapeutic Workshop:
Getting Ahead of Ebola and
Other Infectious Threats
(Jade)
1x1 (7)
BioXcel Corporation
11:30 – 11:55am Corbus Pharmaceuticals Cytokinetics
Protagonist Therapeutics
AcelRx Pharmaceuticals
OncoMed
Pharmaceuticals
1x1 (8)
JDRF
12:00 – 12:55pm Welcome & Opening Plenary Session—Producing “21st
Century Cures” with Chairman Upton and Rep. DeGette (Astor) 1x1 (9/10)
1:00 – 1:25pm
Tetraphase
Pharmaceuticals
Columbia
Laboratories
GenVec
Northwest
Biotherapeutics
GenSpera 1x1 (11)
1:30 – 1:55pm Synthetic Biologics Palatin Technologies Cortendo AB Kite Pharma Regulus Therapeutics Business Roundtable:
How Industry Rates
Interactions
with the FDA (Jade)
1x1 (12)
2:00 – 2:25pm Hansa Medical Geron Corporation RedHill Biopharma ImmunoCellular PDL BioPharma 1x1 (13)
2:30 – 2:55pm Probiodrug AG Advaxis CymaBay Therapeutics TG Therapeutics Apricus Biosciences 1x1 (14)
3:00 – 3:25pm BioTie Therapies Heat Biologics GlycoMimetics GlobeImmune Codexis Business Roundtable:
Digital Health—Early Successes
for Investors and R&D
Productivity (Jade)
1x1 (15)
3:30 – 3:55pm Neuralstem DARA Biosciences Mast Therapeutics Argos Therapeutics pSivida Corp 1x1 (16)
4:00 – 4:25pm Newron Pharmaceuticals Matinas BioPharma ProMetic Life Sciences CEL-SCI Corporation OHR Pharmaceutical 1x1 (17)
4:30 – 4:55pm
BrainStorm Cell
Therapeutics
Proteon
Therapeutics
ERYTECH Pharma Agenus Inc. Ocular Therapeutix 1x1 (18)
5:00 – 5:25pm
Contravir
Pharmaceuticals
Pieris
Pharmaceuticals
Plasmatech
Biopharmaceuticals
Calithera Biosciences Radius Health 1x1 (19)
5:30 – 6:00pm Alcobra Ltd. CytRx Corporation TBA Egalet Corp La Jolla 1x1 (20)
6:00 – 7:00pm Welcome Reception (Empire Room)
Legend
Blue: Private Company
Green: Patient Advocacy Group
As of 2/3/2015: Schedule subject to change. Waldorf Astoria Hotel www.bio.org/bioceo
- 2 - New York, NY biopartnering@bio.org
Tuesday
Feb 10, 2015
Conrad Duke of Windsor Park South Park North Louis XVI Jade/Astor 1x1s
4
th
Floor 3
rd
Floor 8
th
Floor
6:30 – 7:55am Networking Breakfast (6:30-7:30 am): Grand Ballroom---Partnering Begins at 7:00am 1x1 (21/22)
8:00 – 8:25am Cesca Therapeutics NanoViricides DURECT Corporation Trevena Lexicon Pharmaceuticals Therapeutic Workshop:
“Trust Your Gut”—
Therapeutic Opportunities
from the Microbiome
(Jade)
1x1 (23)
8:30 – 8:55am
Oramed
Pharmaceuticals
Conatus
Pharmaceuticals
Adaptimmune Amarantus BioScience
Holdings
Synergy Pharmaceuticals 1x1 (24)
Theraclone Sciences
9:00 – 9:25am
Rexahn
Pharmaceuticals
Relypsa
Spring Bank
Pharmaceuticals BioLineRx Versartis 1x1 (25)
BeiGene
9:30 – 9:55am
Onconova
Therapeutics
Neovacs SA
Diffusion Pharmaceuticals
Tonix Pharmaceuticals Cerulean Pharma 1x1 (26)
Tolero Pharmaceuticals
10:00 – 10:25am
Cyclacel
Pharmaceuticals
Stemline Therapeutics
Leukemia & Lymphoma
Society uniQure N.V. Alkermes Fireside Chat:
John F. Milligan, PhD,
President & COO, Gilead
Sciences (Astor)
1x1 (27)
Dimension Therapeutics
10:30 – 10:55am Ziopharm Oncology OXiGENE
Opsona Therapeutics
Macrocure Ltd. Arena Pharmaceuticals 1x1 (28)
Hydra Biosciences
11:00 – 11:25am Galena Biopharma Selvita S.A.
Sutro Biopharma
Athersys Santhera Pharmaceuticals Fireside Chat:
John Maraganore, PhD,
CEO, Alnylam (Astor)
1x1 (29)
Lycera
11:30 – 11:55am Trillium Therapeutics
Celator
Pharmaceuticals
Genkyotex SA
Celladon Corporation Anavex Life Sciences 1x1 (30)
Alpha-1 Foundation
12:00 – 12:55pm
(Box Lunch)
Plenary Lunch: Following Venture Flow by Disease Indication (Jade) 1x1 (31/32)
1:00 – 1:25pm MabVax Therapeutics
NovaBay
Pharmaceuticals
BriaCell Therapeutics Aerie Pharmaceuticals TiGenix N.V. 1x1 (33)
1:30 – 1:55pm Soligenix Verastem
Actinium
Pharmaceuticals
Eleven Biotherapeutics Horizon Pharma Fireside Chat:
Peter Greenleaf, CEO,
Sucampo (Astor)
1x1 (34)
2:00 – 2:25pm
KaloBios
Pharmaceuticals
Immune
Pharmaceuticals
Cleveland BioLabs Akebia Therapeutics Rigel Pharmaceuticals 1x1 (35)
2:30 – 2:55pm Aradigm Corporation RestorGenex Curis Inc. NephroGenex Affimed Therapeutics Fireside Chat:
Ron Cohen, MD,
President & CEO, Acorda
(Astor)
1x1 (36)
3:00 – 3:25pm Biota Pharmaceuticals
Provectus
Biopharmaceuticals
Synta Pharmaceuticals Aurinia Pharmaceuticals Progenics Pharmaceuticals 1x1 (37)
3:30 – 4:25pm
Fireside Chat:
Ian C. Read, Chairman & CEO, Pfizer (Astor)
1x1 (38/39)
4:30 – 5:25pm Closing Plenary Session: “What’s Liquidity Got to Do With It?”—Risks in the Market Outlook (Astor) 1x1 (40/41)
5:30 – 6:30pm Closing Happy Hour (Jade)
Legend
Blue: Private Company
Green: Patient Advocacy Group

More Related Content

Similar to Bio ceo 2015 grid 1 30 2015

Sustainable Growth in Connected Health and the Economy
Sustainable Growth in Connected Health and the EconomySustainable Growth in Connected Health and the Economy
Sustainable Growth in Connected Health and the Economy
campone
 
Biotech Lifescience 2011
Biotech Lifescience 2011 Biotech Lifescience 2011
Biotech Lifescience 2011
MMMTechLaw
 
Careplus India
Careplus IndiaCareplus India
Careplus India
bsshwetha
 

Similar to Bio ceo 2015 grid 1 30 2015 (20)

Global summit full agenda 1 (1)
Global summit full agenda 1 (1)Global summit full agenda 1 (1)
Global summit full agenda 1 (1)
 
Sustainable Growth in Connected Health and the Economy
Sustainable Growth in Connected Health and the EconomySustainable Growth in Connected Health and the Economy
Sustainable Growth in Connected Health and the Economy
 
Translating a Trillion Points of Data into Therapies, Diagnostics, and New In...
Translating a Trillion Points of Data into Therapies, Diagnostics, and New In...Translating a Trillion Points of Data into Therapies, Diagnostics, and New In...
Translating a Trillion Points of Data into Therapies, Diagnostics, and New In...
 
ASHMM22.pptx
ASHMM22.pptxASHMM22.pptx
ASHMM22.pptx
 
ConferenceAgenda4541.pdf
ConferenceAgenda4541.pdfConferenceAgenda4541.pdf
ConferenceAgenda4541.pdf
 
4 life research new 310614
4 life research new 3106144 life research new 310614
4 life research new 310614
 
ASX Australian Biotech Market cap list
ASX Australian Biotech Market cap listASX Australian Biotech Market cap list
ASX Australian Biotech Market cap list
 
Atul Butte's presentation at ASHG 2014
Atul Butte's presentation at ASHG 2014Atul Butte's presentation at ASHG 2014
Atul Butte's presentation at ASHG 2014
 
Early phase drug development and the fda roadmap final version 2ax
Early phase drug development and the fda roadmap final version 2axEarly phase drug development and the fda roadmap final version 2ax
Early phase drug development and the fda roadmap final version 2ax
 
Biotech Lifescience 2011
Biotech Lifescience 2011 Biotech Lifescience 2011
Biotech Lifescience 2011
 
2013 05 society for clinical trials
2013 05 society for clinical trials2013 05 society for clinical trials
2013 05 society for clinical trials
 
Michael Festing - MedicReS World Congress 2011
Michael Festing - MedicReS World Congress 2011Michael Festing - MedicReS World Congress 2011
Michael Festing - MedicReS World Congress 2011
 
Acetogenins In Vivo re: McLaughlin
Acetogenins In Vivo re: McLaughlinAcetogenins In Vivo re: McLaughlin
Acetogenins In Vivo re: McLaughlin
 
Atul Butte's presentation at LINCS 2013
Atul Butte's presentation at LINCS 2013Atul Butte's presentation at LINCS 2013
Atul Butte's presentation at LINCS 2013
 
Melanoma Immunotherapy - Dr. Patrick Hwu
Melanoma Immunotherapy - Dr. Patrick HwuMelanoma Immunotherapy - Dr. Patrick Hwu
Melanoma Immunotherapy - Dr. Patrick Hwu
 
Targeting Biological Aging: A New Paradigm for 21st Century Medicine
Targeting Biological Aging: A New Paradigm for 21st Century MedicineTargeting Biological Aging: A New Paradigm for 21st Century Medicine
Targeting Biological Aging: A New Paradigm for 21st Century Medicine
 
Careplus India
Careplus IndiaCareplus India
Careplus India
 
Akhu Therapeutics Pitch Deck
Akhu Therapeutics Pitch DeckAkhu Therapeutics Pitch Deck
Akhu Therapeutics Pitch Deck
 
Usfda
UsfdaUsfda
Usfda
 
acs talk open source drug discovery
acs talk open source drug discoveryacs talk open source drug discovery
acs talk open source drug discovery
 

More from John Redaelli

More from John Redaelli (20)

Additional insured primary non contibutory sample
Additional insured primary  non  contibutory sampleAdditional insured primary  non  contibutory sample
Additional insured primary non contibutory sample
 
Insurance requirements
Insurance requirementsInsurance requirements
Insurance requirements
 
Declaration of non employee status-electronic fillable form
Declaration of non employee  status-electronic fillable formDeclaration of non employee  status-electronic fillable form
Declaration of non employee status-electronic fillable form
 
Declaration of permittee automobile-electronic fillable form
Declaration of   permittee automobile-electronic fillable formDeclaration of   permittee automobile-electronic fillable form
Declaration of permittee automobile-electronic fillable form
 
Bocce ball letter of conditions 2021
Bocce ball letter of conditions  2021Bocce ball letter of conditions  2021
Bocce ball letter of conditions 2021
 
Bocce Rules King of the Hill (cut throat) By, John Redaelli
Bocce Rules King of the Hill (cut throat) By, John RedaelliBocce Rules King of the Hill (cut throat) By, John Redaelli
Bocce Rules King of the Hill (cut throat) By, John Redaelli
 
08 10-18 athx overview (investor) - website
08 10-18 athx overview (investor) -  website08 10-18 athx overview (investor) -  website
08 10-18 athx overview (investor) - website
 
9/11/2017 Revised Bocce Courts 4 HB (Huntington Beach)
9/11/2017 Revised Bocce Courts 4 HB (Huntington Beach)9/11/2017 Revised Bocce Courts 4 HB (Huntington Beach)
9/11/2017 Revised Bocce Courts 4 HB (Huntington Beach)
 
Artwork by Paul Redaelli
Artwork by Paul RedaelliArtwork by Paul Redaelli
Artwork by Paul Redaelli
 
June 2015 stem-cell-commercialization-anna-cauldwell2
June 2015 stem-cell-commercialization-anna-cauldwell2June 2015 stem-cell-commercialization-anna-cauldwell2
June 2015 stem-cell-commercialization-anna-cauldwell2
 
Paul Redaelli Resume 20150807-125826871
Paul Redaelli Resume 20150807-125826871Paul Redaelli Resume 20150807-125826871
Paul Redaelli Resume 20150807-125826871
 
Astellas to Acquire Ocata Therapeutics
Astellas to Acquire Ocata TherapeuticsAstellas to Acquire Ocata Therapeutics
Astellas to Acquire Ocata Therapeutics
 
Astellas to Acquire Ocata Therapeutics
Astellas to Acquire Ocata Therapeutics Astellas to Acquire Ocata Therapeutics
Astellas to Acquire Ocata Therapeutics
 
2014 10-15-schwartz-et-al–lancet-2014 (2)
2014 10-15-schwartz-et-al–lancet-2014 (2)2014 10-15-schwartz-et-al–lancet-2014 (2)
2014 10-15-schwartz-et-al–lancet-2014 (2)
 
Ocata corp-presentation-september-2015-2-4
Ocata corp-presentation-september-2015-2-4Ocata corp-presentation-september-2015-2-4
Ocata corp-presentation-september-2015-2-4
 
Arm q2 2015_web%20version_final
Arm q2 2015_web%20version_finalArm q2 2015_web%20version_final
Arm q2 2015_web%20version_final
 
Piis0140 6736(15)61203-x
Piis0140 6736(15)61203-xPiis0140 6736(15)61203-x
Piis0140 6736(15)61203-x
 
Piis0140 6736(15)61201-6
Piis0140 6736(15)61201-6Piis0140 6736(15)61201-6
Piis0140 6736(15)61201-6
 
Ocata therapeuticscorppres june2015-offering
Ocata therapeuticscorppres june2015-offeringOcata therapeuticscorppres june2015-offering
Ocata therapeuticscorppres june2015-offering
 
2015 bioa klimanskaya_irina
2015 bioa klimanskaya_irina2015 bioa klimanskaya_irina
2015 bioa klimanskaya_irina
 

Bio ceo 2015 grid 1 30 2015

  • 1. As of 2/3/2015: Schedule subject to change. Waldorf Astoria Hotel www.bio.org/bioceo - 1 - New York, NY biopartnering@bio.org Monday Feb 9, 2015 Conrad Duke of Windsor Park South Park North Louis XVI Jade/Astor 1x1 Timeslots 4 th Floor 3 rd Floor 8 th Floor 6:30 – 8:00am Networking Breakfast: Grand Ballroom 8:00 – 8:25am Admedus Ltd. CASI Pharmaceuticals TBA Innovus Pharma Genocea BioSciences Therapeutic Workshop: Personalizing Oncology Treatments (Jade) 1x1 (1)Highland Therapeutics 8:30 – 8:55am StemCells Inc. Cellectar Biosciences Global Blood Therapeutics Cara Therapeutics Dipexium Pharmaceuticals 1x1 (2)Michael J. Fox Foundation 9:00 – 9:25am RXi Pharmaceuticals Novogen MaxCyte Aquinox Pharmaceuticals ContraFect Corporation 1x1 (3) KineMed, Inc. 9:30 – 9:55am Ocata Therapeutics OncoSec Medical EnGeneIc Biotron Inovio Pharmaceuticals Business Roundtable: Emerging Trends in Deal Structures (Jade) 1x1 (4) G1 Therapeutics 10:00 – 10:25am Navidea Biopharmaceuticals NeoStem Syndax Pharmaceuticals Pfenex Immunovaccine Inc. 1x1 (5) Mirna Therapeutics 10:30 – 10:55am Can-Fite Biopharma Resverlogix Isarna Therapeutics Marinus Pharmaceuticals EnteroMedics 1x1 (6) Anergis SA 11:00 – 11:25am Opexa Therapeutics SciClone Pharmaceuticals Juventas Therapeutics Recro Pharma Ligand Pharmaceuticals Therapeutic Workshop: Getting Ahead of Ebola and Other Infectious Threats (Jade) 1x1 (7) BioXcel Corporation 11:30 – 11:55am Corbus Pharmaceuticals Cytokinetics Protagonist Therapeutics AcelRx Pharmaceuticals OncoMed Pharmaceuticals 1x1 (8) JDRF 12:00 – 12:55pm Welcome & Opening Plenary Session—Producing “21st Century Cures” with Chairman Upton and Rep. DeGette (Astor) 1x1 (9/10) 1:00 – 1:25pm Tetraphase Pharmaceuticals Columbia Laboratories GenVec Northwest Biotherapeutics GenSpera 1x1 (11) 1:30 – 1:55pm Synthetic Biologics Palatin Technologies Cortendo AB Kite Pharma Regulus Therapeutics Business Roundtable: How Industry Rates Interactions with the FDA (Jade) 1x1 (12) 2:00 – 2:25pm Hansa Medical Geron Corporation RedHill Biopharma ImmunoCellular PDL BioPharma 1x1 (13) 2:30 – 2:55pm Probiodrug AG Advaxis CymaBay Therapeutics TG Therapeutics Apricus Biosciences 1x1 (14) 3:00 – 3:25pm BioTie Therapies Heat Biologics GlycoMimetics GlobeImmune Codexis Business Roundtable: Digital Health—Early Successes for Investors and R&D Productivity (Jade) 1x1 (15) 3:30 – 3:55pm Neuralstem DARA Biosciences Mast Therapeutics Argos Therapeutics pSivida Corp 1x1 (16) 4:00 – 4:25pm Newron Pharmaceuticals Matinas BioPharma ProMetic Life Sciences CEL-SCI Corporation OHR Pharmaceutical 1x1 (17) 4:30 – 4:55pm BrainStorm Cell Therapeutics Proteon Therapeutics ERYTECH Pharma Agenus Inc. Ocular Therapeutix 1x1 (18) 5:00 – 5:25pm Contravir Pharmaceuticals Pieris Pharmaceuticals Plasmatech Biopharmaceuticals Calithera Biosciences Radius Health 1x1 (19) 5:30 – 6:00pm Alcobra Ltd. CytRx Corporation TBA Egalet Corp La Jolla 1x1 (20) 6:00 – 7:00pm Welcome Reception (Empire Room) Legend Blue: Private Company Green: Patient Advocacy Group
  • 2. As of 2/3/2015: Schedule subject to change. Waldorf Astoria Hotel www.bio.org/bioceo - 2 - New York, NY biopartnering@bio.org Tuesday Feb 10, 2015 Conrad Duke of Windsor Park South Park North Louis XVI Jade/Astor 1x1s 4 th Floor 3 rd Floor 8 th Floor 6:30 – 7:55am Networking Breakfast (6:30-7:30 am): Grand Ballroom---Partnering Begins at 7:00am 1x1 (21/22) 8:00 – 8:25am Cesca Therapeutics NanoViricides DURECT Corporation Trevena Lexicon Pharmaceuticals Therapeutic Workshop: “Trust Your Gut”— Therapeutic Opportunities from the Microbiome (Jade) 1x1 (23) 8:30 – 8:55am Oramed Pharmaceuticals Conatus Pharmaceuticals Adaptimmune Amarantus BioScience Holdings Synergy Pharmaceuticals 1x1 (24) Theraclone Sciences 9:00 – 9:25am Rexahn Pharmaceuticals Relypsa Spring Bank Pharmaceuticals BioLineRx Versartis 1x1 (25) BeiGene 9:30 – 9:55am Onconova Therapeutics Neovacs SA Diffusion Pharmaceuticals Tonix Pharmaceuticals Cerulean Pharma 1x1 (26) Tolero Pharmaceuticals 10:00 – 10:25am Cyclacel Pharmaceuticals Stemline Therapeutics Leukemia & Lymphoma Society uniQure N.V. Alkermes Fireside Chat: John F. Milligan, PhD, President & COO, Gilead Sciences (Astor) 1x1 (27) Dimension Therapeutics 10:30 – 10:55am Ziopharm Oncology OXiGENE Opsona Therapeutics Macrocure Ltd. Arena Pharmaceuticals 1x1 (28) Hydra Biosciences 11:00 – 11:25am Galena Biopharma Selvita S.A. Sutro Biopharma Athersys Santhera Pharmaceuticals Fireside Chat: John Maraganore, PhD, CEO, Alnylam (Astor) 1x1 (29) Lycera 11:30 – 11:55am Trillium Therapeutics Celator Pharmaceuticals Genkyotex SA Celladon Corporation Anavex Life Sciences 1x1 (30) Alpha-1 Foundation 12:00 – 12:55pm (Box Lunch) Plenary Lunch: Following Venture Flow by Disease Indication (Jade) 1x1 (31/32) 1:00 – 1:25pm MabVax Therapeutics NovaBay Pharmaceuticals BriaCell Therapeutics Aerie Pharmaceuticals TiGenix N.V. 1x1 (33) 1:30 – 1:55pm Soligenix Verastem Actinium Pharmaceuticals Eleven Biotherapeutics Horizon Pharma Fireside Chat: Peter Greenleaf, CEO, Sucampo (Astor) 1x1 (34) 2:00 – 2:25pm KaloBios Pharmaceuticals Immune Pharmaceuticals Cleveland BioLabs Akebia Therapeutics Rigel Pharmaceuticals 1x1 (35) 2:30 – 2:55pm Aradigm Corporation RestorGenex Curis Inc. NephroGenex Affimed Therapeutics Fireside Chat: Ron Cohen, MD, President & CEO, Acorda (Astor) 1x1 (36) 3:00 – 3:25pm Biota Pharmaceuticals Provectus Biopharmaceuticals Synta Pharmaceuticals Aurinia Pharmaceuticals Progenics Pharmaceuticals 1x1 (37) 3:30 – 4:25pm Fireside Chat: Ian C. Read, Chairman & CEO, Pfizer (Astor) 1x1 (38/39) 4:30 – 5:25pm Closing Plenary Session: “What’s Liquidity Got to Do With It?”—Risks in the Market Outlook (Astor) 1x1 (40/41) 5:30 – 6:30pm Closing Happy Hour (Jade) Legend Blue: Private Company Green: Patient Advocacy Group